Clinical trial

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

NCT05283616

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pegfilgrastim Normalized identity: pegfilgrastimView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-05-15

PhasePHASE3

Conditions

Neutropeniaverified · MONDO: neutropenia

Interventions

PegfilgrastimDRUG · verified · RxNorm: pegfilgrastim

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05283616 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.